New podcast long read – Patient's advocate

Communications / 27 November 2020

The latest episode of the Drug Safety Matters podcast has dropped. Tune in to hear Marie Lindquist reflect on a career dedicated to patient safety.

In November 2020, longstanding UMC director Marie Lindquist began her well-earned retirement, leaving the reins of the organisation to her successor Hervé Le Louët. As she prepared to open a new chapter in her life, she sat down with Uppsala Reports to take a fond look back at an extraordinary career: a 40-year-long path that began with a knock on the door and turned her into one of the world’s leading advocates for patient safety.

This episode is part of the Drug Safety Matters Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Tags: podcast, PatientSafety

You may also like

New podcast episode – Into the infodemic

Tune in to the latest in our Drug Safety Matters Long Reads series, exploring how pharmacovigilance experts can help win the war on viral misinformation – by not fighting it.

Communications / 29 March 2021

New podcast drops – How do we change behaviour around antimicrobial resistance?

Antimicrobial resistance threatens one of the key pillars of modern medicine. The latest episode of Drug Safety Matters asks how we got here – and how we get out.

Communications / 27 April 2021

Good news – The newsletter is back

Email newsletter are back in style. And for health communicators in a time of pandemic, one could argue that they have have never been more useful.

Communications / 29 March 2021

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more